Background/Objectives: The global prevalence of obesity and type 2 diabetes mellitus (T2DM) has been steadily increasing, and these interrelated disorders share common pathophysiological mechanisms, including altered levels of adipokines secreted from adipose tissue. Among these, chemerin and visfatin have been suggested as potential biomarkers for obesity-related metabolic dysfunction. This study aimed to evaluate the relationship between serum chemerin and visfatin levels and obesity in patients with T2DM. Methods: The study included 74 obese T2DM patients, 60 non-obese T2DM patients, and 36 healthy controls. Serum chemerin and visfatin levels were measured using an enzyme-linked immunosorbent assay (ELISA). Clinical parameters including HbA1c, fasting plasma glucose, insulin, and Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) were assessed. Between-group comparisons were performed using appropriate parametric or non-parametric tests with Bonferroni correction for multiple comparisons. ROC curve analysis was applied to evaluate the diagnostic performance of visfatin. Results: Serum visfatin levels were significantly higher in the T2DM (33.00 ± 20.61) groups compared to controls (30.25 ± 26.40; p = 0.01), while chemerin levels showed no significant difference. HbA1c and glucose levels were elevated in both diabetic groups, whereas insulin and HOMA-IR were significantly higher only in the obese T2DM group. Receiver operating characteristic (ROC) analysis revealed limited diagnostic accuracy of visfatin (AUC < 0.70). Conclusions: Visfatin levels were modestly higher in obese T2DM patients, while chemerin did not differ significantly among groups. However, the diagnostic performance of visfatin was limited (AUC < 0.70), and these findings should be regarded as exploratory. Larger, well-controlled studies are required to clarify whether visfatin or chemerin could have any clinical utility as part of multi-marker approaches.
7 February 2022 in International Journal of Science Letters
The earth rotates around its axis for 24 hours, this process creates physiological, biochemical, and behavioral rhythms in living things. These one-day periods are called the circadian rhythm. The circadian rhythm regulates human physiology and behavior by responding to environmental stimuli around the clock. The circadian system and sleep/wake phases are intertwined, and conditions such as sleep disorders, exposure to artificial light, jet lag, and shift work may cause disruptions in the circadian rhythm. Circadian rhythm; It is effective in gastrointestinal system physiology such as cell proliferation, electrolyte balance, digestion, absorption, motility. Disturbances in the circadian rhythm can cause imbalances in the intestinal flora, which can lead to disruptions in both the immune system and the absorption and digestion of macronutrients. In the human body, many endocrine factors are secreted in 24-hour periods and the amount of secretion reaches its peak at certain hours during the day. Disturbances in the circadian rhythm can cause many pathological conditions such as obesity and diabetes by causing disorders in the gastrointestinal system physiology, the secretion function of appetite hormones, and other endocrine factors secreted in 24 hours. Our aim in this review is to discuss the effects of circadian rhythm on gastrointestinal health and the relationship of hormones fluctuating with 24-hour circadian rhythm and obesity. The search was conducted in peer-reviewed journals PubMed, Web of Science, and Google Scholar. For this purpose, the keywords circadian rhythm and obesity were used together and research articles were included in this study.
31 August 2021 in Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi
AMAÇ: COVID-19 salgını sürecinde, virüsün yayılım hızını düşürmek ve sosyal izolasyon sağlamak amacıyla tıp eğitiminin uygulanışı ile ilgili esaslar da zorunlu bir değişikliğe uğramıştır. Bu çalışmada Ufuk Üniversitesi Tıp Fakültesi öğrencilerinin, COVID-19 salgını sürecinde yürütülen çevrimiçi eğitime bakış açılarının ve sürecin verimliliği hakkındaki görüşlerinin değerlendirilmesi amaçlanmıştır. GEREÇ VE YÖNTEM: Çalışma salgın sürecinde eğitimlerine çevrimiçi platformda devam eden ve yine çevrimiçi ortamdan gönderilen ankete erişim sağlayan 235 öğrenci ile gerçekleştirildi. Genel demografik bilgiler, çevrimiçi eğitim platformunu kullanım ve erişim bilgileri, öğrenim materyallerine erişim ve kullanım bilgileri, çevrimiçi derslere katılım bilgileri, çevrimiçi eğitimin öğrenme süreçlerine etkileri ve verimliliği, son olarak da yüz yüze eğitim varlığında çevrimiçi eğitimin yeri hakkındaki görüşleri değerlendirildi. Veriler 5’li Likert ölçeği kullanılarak elde edildi ve IBM SPSS 20.0.0 paket programında değerlendirildi. BULGULAR: Çalışmaya katılan öğrencilerin yalnızca %37,4’ ünün çevrimiçi eğitimi verimli buldukları belirlendi. Öğrenciler derslere motive olmakta zorlandıklarını (%61,2) ancak kolaylıkla uyum sağladıklarını (%51,1), dersleri ilgi çekici bulduklarını (%29,3), öğretim üyesini görmenin avantajlı olduğunu (%50,7) bildirdiler. Bununla birlikte çevrimiçi eğitimdeki görsel sunumların yüz yüze eğitime üstün olduğunu (%34,9), çevrimiçi eğtimin mekandan ve zamandan bağımsız olduğunu (%79,8) ve çevrimiçi eğitimin yüz yüze eğitimin bir parçası olmasını gerektiğini (%52,4) bildirdiler. SONUÇ: Salgın sürecinde hızla yapılandırılan çevrimiçi eğitimin öğrenci perspektifinden değerlendirilmesi ve sürece yansımalarının dikkate alınması çevrimiçi eğitimin ve tıp eğitiminin geleceğiyle ilgili birtakım değişikliklere sürdürülebilir çözüm olabilir.
1 January 2024 in Revista da Associação Médica Brasileira
Obesity is an increasingly prevalent global health problem, which is generally caused by the increase in body fat mass above normal and observed in all societies. If the blood glucose level is higher than normal but not high enough to diagnose diabetes, this condition is defined as prediabetes. Adiponectin increases fatty acid oxidation and insulin sensitivity and is closely associated with obesity. One of the nuclear receptor superfamily member peroxisome proliferator-activated receptors is shown to have an important role in various metabolic reactions. This study aimed to investigate the serum levels of adiponectin and peroxisome proliferator-activated receptors-gamma parameters, which are closely related to adipose tissue, energy metabolism, and insulin sensitivity, in obese patients with and without prediabetes.
1 January 2025 in Revista da Associação Médica Brasileira
OBJECTIVE: This study aims to examine whether the presence of mutation exists in the vitamin D-connector protein gene rs7041 variant of the pancreatitis table for patients diagnosed with coronavirus disease 2019.
This study aimed to investigate the immediate effects of manual therapy (MT) on the respiratory functions of healthy young individuals. The study included 104 participants, consisting of university students (87 females, 17 males, mean age 20.1 ± 2.2). Participants were randomly assigned to the MT (experimental; n = 52) and sham-MT (control; n = 52) groups. The experimental group underwent thoracic manipulations and mobilizations along with diaphragm mobilization. In the control group, the hands were placed on the same regions, but no specific intervention was applied. All participants underwent respiratory function testing before and after the intervention using a portable spirometer (PEF- Peak expiratory flow; FEV 1- Forced expiratory volume in 1 s; FVC- Forced vital capacity and FEV1/FVC- Tiffeneau index). In the experimental group, there was a significant increase in the mean PEF value following MT application from 296.3 ± 110.8 to 316.1 ± 119.1 (p = 0.018). Conversely, the mean PEF value in the control group showed a slight decrease from 337.1 ± 93.3 to 324.5 ± 89.2 (p = 0.002). No significant changes were observed in FVC, FEV1, or FEV1/FVC values pre- and post-intervention in either groups. A single MT session led to a significant improvement in PEF in healthy young individuals. Further research is needed to explore the long-term effects of MT on respiratory functions and its potential implications in clinical practice. Trial registration ClinicalTrials.gov: NCT05934240 (06/07/2023).